Details for New Drug Application (NDA): 076925
✉ Email this page to a colleague
The generic ingredient in IBUPROFEN is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
Summary for 076925
Tradename: | IBUPROFEN |
Applicant: | Padagis Us |
Ingredient: | ibuprofen |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 076925
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 076925
Suppliers and Packaging for NDA: 076925
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 076925 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-952 | 45802-952-26 | 1 BOTTLE in 1 CARTON (45802-952-26) / 120 mL in 1 BOTTLE |
IBUPROFEN | ibuprofen | SUSPENSION;ORAL | 076925 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-952 | 45802-952-43 | 473 mL in 1 BOTTLE (45802-952-43) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 100MG/5ML | ||||
Approval Date: | Sep 23, 2004 | TE: | AB | RLD: | No |
Complete Access Available with Subscription